SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178253-17-000015
Filing Date
2017-08-08
Accepted
2017-08-08 16:02:55
Documents
64
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-qx63017.htm 10-Q 736995
2 EXHIBIT 31.1 exhibit311-63017.htm EX-31.1 12097
3 EXHIBIT 31.2 exhibit312-63017.htm EX-31.2 11996
4 EXHIBIT 32.1 exhibit321-63017.htm EX-32.1 8695
  Complete submission text file 0001178253-17-000015.txt   4684752

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT scyx-20170630.xml EX-101.INS 907183
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scyx-20170630.xsd EX-101.SCH 39754
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scyx-20170630_cal.xml EX-101.CAL 64617
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scyx-20170630_def.xml EX-101.DEF 181563
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scyx-20170630_lab.xml EX-101.LAB 517346
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scyx-20170630_pre.xml EX-101.PRE 326630
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 171014655
SIC: 2834 Pharmaceutical Preparations